
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Neurol. , 15 March 2023
Sec. Neuromuscular Disorders and Peripheral Neuropathies
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1179017
This article is a correction to:
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
A corrigendum on
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
by Huang, X., Ran, H., Li, Y., Ma, Q., Ou, C., Qiu, L., Feng, H., and Liu, W. (2022). Front Neurol. 13:961628. doi: 10.3389/fneur.2022.961628
In the published article, an author name was incorrectly written as Yingkia Li. The correct spelling is Yingkai Li.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: myasthenia gravis, leflunomide, low dose prednisone, Th1 cells, Th2 cells, Th17 cells, Th9 cells
Citation: Huang X, Ran H, Li Y, Ma Q, Ou C, Qiu L, Feng H and Liu W (2023) Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients. Front. Neurol. 14:1179017. doi: 10.3389/fneur.2023.1179017
Received: 03 March 2023; Accepted: 06 March 2023;
Published: 15 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Huang, Ran, Li, Ma, Ou, Qiu, Feng and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huiyu Feng, ZmVuZ2h1aXlAbWFpbC5zeXN1LmVkdS5jbg==; Weibin Liu, bGl1d2JAbWFpbC5zeXN1LmVkdS5jbg==
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.